Group picture Left to right: Ashley Wheeler, - Executive General Manager, Epworth Eastern, Dr Nicholas Wilsmore and Sally McKnight - Associate Director of Clinical Services.

Epworth Eastern is advancing the field of interventional pulmonology, thanks to its hybrid theatre and the integration of robotic imaging technology that is transforming respiratory medicine.

Leading this important initiative is Dr Nicholas Wilsmore, a renowned expert in respiratory and sleep medicine, specialising in interventional pulmonology. With the latest robotic imaging technology at his disposal, Dr Wilsmore is on a mission to establish new standards in respiratory health.

"The innovative robotic imaging technology within our hybrid theatre is revolutionising the way precise and intricate procedures are conducted," says Dr Wilsmore. "Particularly, in the field of interventional pulmonology, where the smallest detail can impact patient outcomes, this technology's precision is paramount. It allows us to delve deeper into diagnoses and treatments, providing patients with more effective and less invasive options."

This advanced system boasts augmented fluoroscopy and airway mapping, enabling Dr Wilsmore to perform interventions with accuracy, transforming the diagnoses and treatment of respiratory conditions, including new techniques to treat early-stage lung cancer.

Dr Wilsmore was recently awarded a prestigious scholarship from the Epworth Medical Foundation (EMF). This scholarship supported his educational journey to NTU Park Biomedical Hospital in Taiwan, where he learned from global practitioners in interventional pulmonology. These learnings have expanded the potential for advanced procedures to be delivered at Epworth.

Ashley Wheeler, Executive General Manager at Epworth Eastern, celebrates this advancement. He says, "The integration of this technology and Dr Nicholas Wilsmore's expertise signifies a leap forward in interventional pulmonology at Epworth. As we advance patient care, we are confident that this new system will lead to new diagnostics and treatment for respiratory health."


We use cookies to provide you with a customised experience which may include marketing purposes. More details can be found at our Privacy Policy.